J Exp Clin Cancer Res 2008, 27:49.PubMedCrossRef 15. Shekari M, Sobti RC, Tamandani DM, Malekzadeh K, Kaur P, Suri V: Association of genetic polymorphism of the DNA base excision repair gene (APE-1 Asp/148 Glu) and HPV type (16/18) with the risk of cervix cancer in north Indian population. Cancer Biomark 2008, 4:63–71.PubMed 16. Yoo DG, Song YJ, Cho EJ, Lee SK, Park JB, Yu JH, Lim SP, Kim

JM, Jeon BH: Alteration of APE1/ref-1 expression in non-small cell lung cancer: the implications of impaired extracellular Belinostat manufacturer superoxide dismutase and catalase antioxidant systems. Lung Cancer 2008, 60:277–284.PubMedCrossRef 17. van Baardwijk A, Dooms C, van Suylen RJ, Verbeken E, Hochstenbag M, Dehing-Oberije C, Rupa D, Pastorekova S, Stroobants S, Buell U, et al.: The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer. Eur J Cancer 2007, 43:1392–1398.PubMedCrossRef 18. Kaira

K, Oriuchi N, Shimizu K, Ishikita T, Higuchi T, Imai H, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, et al.: Correlation of angiogenesis with (18)F-FMT and (18)F-FDG uptake in non-small cell lung cancer. Cancer Sci 2009, 100:753–758.PubMedCrossRef 19. Hodgkinson AD, Page T, Millward BA, Demaine AG: A novel polymorphism in the 5′ flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with Type Epigenetics Compound Library solubility dmso 1 diabetes mellitus. J Diabetes Complications 2005, 19:65–69.PubMedCrossRef 20. Matakidou A, el Galta R, Webb EL, Rudd MF, Bridle H, the GC, Eisen T, Houlston RS: Genetic variation in the DNA repair genes is predictive of outcome in lung cancer. Hum Mol Genet 2007, 16:2333–2340.PubMedCrossRef 21. Hanin FX, Lonneux M, Cornet J, Noirhomme P, Coulon C, Distexhe J, Poncelet AJ: Prognostic value of FDG uptake in Resminostat early stage non-small cell lung cancer. Eur J Cardiothorac Surg 2008, 33:819–823.PubMedCrossRef 22. Usuda K, Saito Y, Sagawa M, Sato M, Kanma

K, Takahashi S, Endo C, Chen Y, Sakurada A, Fujimura S: Tumor doubling time and prognostic assessment of patients with primary lung cancer. Cancer 1994, 74:2239–2244. PubMedCrossRef 23. Duhaylongsod FG, Lowe VJ, Patz EF Jr, Vaughn AL, Coleman RE, Wolfe WG: Lung tumor MLN4924 nmr growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg 1995, 60:1348–1352.PubMedCrossRef 24. Liu ZH, Guan TJ, Chen ZH, Li LS: Glucose transporter (GLUT1) allele (XbaI-) associated with nephropathy in non-insulin-dependent diabetes mellitus. Kidney Int 1999, 55:1843–1848.PubMedCrossRef 25. Tarnow L, Grarup N, Hansen T, Parving HH, Pedersen O: Diabetic microvascular complications are not associated with two polymorphisms in the GLUT-1 and PC-1 genes regulating glucose metabolism in Caucasian type 1 diabetic patients. Nephrol Dial Transplant 2001, 16:1653–1656.PubMedCrossRef 26.